RAS water treatment specialist appoints Ohad Maiman
BioFishency reinforces global presence powered by a team of market-savvy industry leaders.
BioFishency, a provider of electro-chemical and biological water treatment solutions for RAS, has named RAS expert and venture capital frontrunner, Ohad Maiman, as its new chairman of the board. In his new role, Maiman will leverage his unique experience, enabling BioFishency to reinforce its position as one of the world’s leading disruptive RAS water treatment solutions providers.
Maiman is the founder and managing partner of AquaFounders Capital, an investment company focused on securing a strategic position in the land-based aquaculture sector across the value chain. Prior, Maiman was founder and CEO at the Kingfish Company, where he led the company to becoming one of the world's flagship RAS producers with the development of land-based RAS yellowtail kingfish in the Netherlands and the USA.
“Few components in a RAS system are as critical as the filter unit, and replacing the biofilter with an electro-chemical process eliminates crucial uncertainties, and holds the promise of disrupting the sector by significantly improving reliability and efficiency,” said Maiman. “Recognizing the inherent value of BioFishency’s innovative water treatment solutions, their in-depth understanding of market requirements, and the company’s skilled and professional team, prompted my decision to get onboard. I am confident that BioFishency is poised to deliver on its immense potential, and I look forward to working with management and the board to support the company as it builds on its strong foundation, and expands its operations around the globe.”
“We could not be prouder to have Ohad Maiman join BioFishency as Chairman of the Board. It is a true testament to the future of the company,” said BioFishency CEO, Michael Isakov. “Ohad brings unrivaled business acumen in founding and leading land-based aquaculture initiatives, matched with an unprecedented track record in his knowledge and understanding of the sector. Working closely with Ohad will result in faster than anticipated success for BioFishency in our outreach to new target markets, while achieving the company’s aggressive goals.”